Axsome Therapeutics Inc.

NASDAQ: AXSM · Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.00
-1.10%
After-hours: Aug 15, 2025, 07:57 PM EDT

Axsome Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-47.97M -59.41M -74.91M -64.6M -79.34M -68.36M -98.65M -62.2M -67.17M -11.22M -61.24M -44.82M -41.44M -39.63M -33.98M -34.88M -32.28M -29.26M
Depreciation & Amortization
1.71M 1.72M 2.07M 2.06M 1.99M 1.83M 1.74M 1.74M 1.38M 1.98M 2.02M 1.96M 1.27M 311.7K 307.41K 299.74K 277.42K 271.09K
Stock-Based Compensation
24.61M 23.31M 21.99M 21.66M 21.38M 20.19M 18.91M 14.84M 15.92M 12.94M 10.77M 9.2M 10.16M 7.6M 5.89M 5.73M 5.46M 3.73M
Other Working Capital
n/a -4.17M 27.1M -16.52M 33.55M -13.2M 13.14M 13.1M 3.25M 4.72M 12.87M 22.52M 6.18M -384.82K -793.98K 311.31K 4.24M -3.08M
Other Non-Cash Items
-10.77M -8.99M 11.85M 38.32M 2.98M 17.14M 44.83M 1.03M 7.13M 105K 4.19M 119.56K -658.25K 8.34K -34.29K 522.00 -71.09K 255.00
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -617K n/a 617K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a n/a 12.8M -16.07M 22.88M -6.81M 3.42M -8.96M -13.23M -9.63M 16.7M 10.78M -2.87M -939.03K -1.03M 2.08M 1.23M -1.96M
Operating Cash Flow
-32.42M -43.38M -26.2M -18.63M -30.11M -53.47M -30.36M -53.55M -55.35M -5.82M -27.56M -22.76M -33.54M -32.65M -28.84M -26.78M -25.39M -27.22M
Capital Expenditures
n/a n/a -30K 150K -52K -98K -7K -371K -133K -71K -180.86K -66.06K -241.46K -213.74K 307.55K -258.68K -18.88K -30K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -53M n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-13K -338K n/a -240K n/a -98K -582K n/a n/a -71K -53,702.1B n/a n/a -213.74B -307.55B n/a n/a -30B
Investing Cash Flow
-13K -338K -30K -90K -52K -98K -7K -371K -133K -71K -180.86K -66.06K -53.24M -213.74K -307.55B -258.68K -18.88K -30K
Debt Repayment
n/a -401K -330K -311K -186K -163K n/a n/a 30M 55M n/a n/a 45M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a -1.33M -1.62M -280K n/a n/a -867K -162.68K n/a n/a n/a -91.7K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.43M 29.27M -1.84M 17.61M 14.56M -1.02M -2K -380K -8.92M -2.57M 1.07M -1.1M -2.09M -88.24K 690.48K 438.68K 874.88K 1.91M
Financial Cash Flow
34.54M 29.27M 14.24M 30.41M 14.38M -1.19M -2K 33.37M 246.08M 51.56M 1.07M 176.95M 75.46M 31.1M 690.48K 438.68K 1.97M 8.03M
Net Cash Flow
2.11M -14.44M -11.99M 11.68M -15.78M -54.75M -30.37M -20.55M 190.6M 45.67M -26.68M 154.13M -11.31M -1.77M -28.15M -26.6M -23.44M -19.22M
Free Cash Flow
-32.42M -43.38M -26.23M -18.48M -30.16M -53.56M -30.37M -53.92M -55.48M -5.89M -27.74M -22.82M -33.78M -32.87M -28.53M -27.03M -25.41M -27.25M